Neuropsychopharmacology
- Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation3 years ago
- Advances in precision neuromodulation: electroconvulsive therapy amplitude titration3 years ago
- Academic ethics of mental health: the national black postdocs framework for the addressment of support for undergraduate and graduate trainees3 years ago
- Polygenic liability for antipsychotic dosage and polypharmacy – a real-world registry and biobank study3 years ago
- Modulation of learning safety signals by acute stress: paraventricular thalamus and prefrontal inhibition3 years ago
- Comparative rhythmic transcriptome profiling of human and mouse striatal subregions3 years ago
- Correction: Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge3 years ago
Journal of Psychopharmacology
- Cariprazine modulates sleep architecture in rats6 years ago
- Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials6 years ago
- Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study6 years ago
- Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature6 years ago
- A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis6 years ago
- Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial6 years ago
- Dopaminergic neuromodulation has no detectable effect on visual-cue induced haemodynamic response function in the visual cortex: A double-blind, placebo-controlled functional magnetic resonance imaging study6 years ago
European Neuropsychopharmacology
- Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise5 years ago
- Are we ready for precision medicine for Autism? And who wants it?5 years ago
- The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years5 years ago
- Drug development in ASD, an ISCTM-ECNP joint adventure5 years ago
- GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site5 years ago
- Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis5 years ago
- Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS)5 years ago